The researchers of a recent study found that participants with an RS of 11-25 had an invasive disease-free survival (IDFS) rate at five years of 92.6 percent with a median follow-up of 58 months.
Scientists ultimately make a great way to reduce the effects of chemotherapy by inventing the DigniCap Cooling System and provides relief to the cancer patients.
